Tan, Chee Wah http://orcid.org/0000-0001-9837-1413
Chia, Wan Ni http://orcid.org/0000-0001-7287-694X
Zhu, Feng
Young, Barnaby E. http://orcid.org/0000-0003-1010-2230
Chantasrisawad, Napaporn
Hwa, Shi-Hsia http://orcid.org/0000-0002-5648-9808
Yeoh, Aileen Ying-Yan
Lim, Beng Lee
Yap, Wee Chee http://orcid.org/0000-0001-8470-5806
Pada, Surinder Kaur M. S.
Tan, Seow Yen
Jantarabenjakul, Watsamon
Toh, Lim Kai
Chen, Shiwei http://orcid.org/0000-0001-6045-8660
Zhang, Jinyan
Mah, Yun Yan
Chen, Vivian Chih-Wei http://orcid.org/0000-0001-8757-0644
Chen, Mark I-C
Wacharapluesadee, Supaporn
Sigal, Alex http://orcid.org/0000-0001-8571-2004
Putcharoen, Opass
Lye, David Chien
Wang, Lin-Fa http://orcid.org/0000-0003-2752-0535
Funding for this research was provided by:
MOH | National Medical Research Council (MOH-000535/MOH-OFYIRG19nov-0002, (STPRG-FY19-001, COVID19RF-003, COVID19RF-060, and OFLCG19May-0034))
Bill and Melinda Gates Foundation (INV-018944)
U.S. Department of Health & Human Services | NIH | Center for Information Technology (R01 AI138546)
South African Medical Research Council (6084-CO-AP-2020)
National Research Foundation Singapore ((NRF2016NRF-NSFC002-013, and NRF2018NRF-NSFC003SB-002)
Article History
Received: 24 June 2022
Accepted: 7 September 2022
First Online: 4 October 2022
Competing interests
: L.-F.W., C.W.T. and W.N.C. are co-inventors of the patented surrogate virus neutralization test marketed by Genscript as cPass<sup>TM</sup>. The other authors declare no competing interests.
Free to read: This content has been made available to all.